Find News

Filter articles

Showing 81 to 90 of 3607 results

Lupin and Sun settle Bromsite patent suit after ruling

US10-02-2022Alex Baldwin

Sun Pharmaceuticals and Lupin Pharmaceuticals have decided to settle a patent suit related to Sun’s Bromsite eye drops, invalidating an opinion handed down by the US District Court for the District of New Jersey in September.

MSF urges South Africa to open access to COVID-19 generics

South Africa10-02-2022

Humanitarian organisation Médecins Sans Frontières has called for the South African government to seek the revocation of COVID-19-related patents granted to Eli Lilly and Moderna.

AstraZeneca, MSD sue MSN and Sandoz over Calquence generics

US08-02-2022Alex Baldwin

AstraZeneca and Merck, Sharp & Dohme have filed a pair of lawsuits against MSN and Sandoz, claiming their planned generic versions of its leukaemia treatment Calquence infringe six patents.

EC reveals plans for unitary SPC, compulsory licences

EU08-02-2022Muireann Bolger

The European Commission will unveil plans to make supplementary protection certificates more accessible and efficient for pharmaceutical companies to register and enforce by the end of March.

PhRMA says EU, WTO, others are ‘weakening’ IP

International07-02-2022Alex Baldwin

Pharmaceutical industry consortium PhRMA has asked the Office of the US Trade Representative to put the European Union, the World Trade Organization and the UK on a watch list of trading partners that could “weaken” IP rights.

Pfizer accuses ex-employees of stealing trade secrets for startup

US03-02-2022Alex Baldwin

Pfizer has sued two of its former executive staffers, alleging that they stole trade secrets related to diabetes medication before leaving the company.

Gilead pays $1.25bn to GSK in HIV drug settlement

US03-02-2022Alex Baldwin

Gilead Sciences has agreed to pay $1.25 billion upfront with additional royalties to GlaxoSmithKline subsidiary ViiV Healthcare to settle claims that it infringed HIV drug patents.

Court dismisses Regeneron’s antitrust countersuit against Novartis


Novartis escaped an antitrust countersuit brought by Regeneron earlier this week, with a New York court dismissing the suit which had been filed in response to Novartis’ patent complaint.

Labour peer says vaccine IP should be waived during a pandemic

UK01-02-2022Alex Baldwin

UK politicians are proposing that the country waive UK registered IP related to vaccines and treatments in the event of a pandemic.

Celgene, Dr Reddy's abandon cancer drug patent dispute

US01-02-2022Muireann Bolger

Bristol-Myers Squibb subsidiary, Celgene has settled its lawsuit against India-based drug maker Dr Reddy's over a generic version of the blockbuster cancer treatment, Pomalyst.

Showing 81 to 90 of 3607 results